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Abstract
Background: Transport of molecules from one subcellular compartment to another involves the recruitment of cytosolic
coat protein complexes to a donor membrane to concentrate cargo, deform the membrane and ultimately to form an
independent carrier. Small-GTP-binding proteins of the Arf family are central to many membrane trafficking events. Arfs are
activated by guanine nucleotide exchange factors (GEFs) which results in their recruitment to membranes and subsequent
engagement with Arf-effectors, many of which are coat proteins. Among the human BFA-sensitive large Arf-GEFs, the
function of the two closely related BIG1 and BIG2 is still not clear, and recent studies have raised the question of functional
redundancy between the two proteins.
Methodology/Principal Findings: Here we have used small-interfering RNA on human cells and a combination of fixed and
live-cell imaging to investigate the differential functions of BIG1 and BIG2 in endomembrane organization and function.
Importantly, in this direct comparative study, we show discrete functions for BIG1 and BIG2. Our results show that depletion
of BIG2 but not of BIG1 induces a tubulation of the recycling endosomal compartment, consistent with a specific role for
BIG2 here. In contrast, suppression of BIG1 induces the formation of Golgi mini-stacks still polarized and functional in terms
of cargo export.
Conclusions: A key finding from our work is that suppression of BIG1 expression results in a fragmentation of the Golgi
apparatus. Our data indicate that the human BFA-sensitive large Arf-GEFs have non-redundant functions in cell organization
and membrane trafficking. BIG1 is required to maintain the normal morphology of the Golgi; BIG2 is important for
endosomal compartment integrity and cannot replace the function of BIG1 in Golgi organization.
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Introduction
The transport of proteins and lipids between different
compartments of the secretory pathway involves the budding of
a coated vesicle from a donor compartment. This process involves
the selection and incorporation of a cargo protein into nascent
vesicles, followed by scission from the donor compartment, release
of the coat, and subsequent transport of the vesicle to the acceptor
compartment. Membrane fusion completes the transfer of cargo to
the acceptor compartment [1]. Several coat complexes are
recruited in different sub-compartments: the COPII machinery
is recruited on the endoplasmic reticulum exit sites (ERES) and
directs cargo export from the ER and transit to the ER-Golgi
intermediate compartment (ERGIC). Subsequent transport steps
require the COPI machinery, believed to regulate both antero-
grade and retrograde trafficking between the Golgi and the
ERGIC [2]. Transport at the TGN boundary includes the
formation of clathrin-coated vesicles where clathrin is recruited by
different adaptor proteins including the multimeric AP-1, AP-3
and AP-4 [3] as well as the monomeric gamma ear Golgi-localized
Arf-binding proteins (GGAs) [1].
The formation of coated vesicles depends on the tightly
controlled activation of several small GTP-binding proteins. As
Sar1 initiates the recruitment of COPII [4], the ADP-ribosylation
factors (Arfs) recruit the other coats [5]. Mammalian Arfs are
subdivided into three classes according to sequence homology:
class I (Arf1, 3), class II (Arf4, 5), and the sole known member for
class III Arf6 [5]. Arfs act as molecular switches, cycling between
an inactive GDP-bound state and an active GTP-bound state.
GTP-bound Arfs specify the recruitment of downstream effectors
including these adaptors and therefore Arf activation is critical to
the core mechanism and fidelity of membrane traffic. Arf
activation through GDP-GTP exchange is mediated by guanine
nucleotide exchange factors (GEFs) [6,7].
Arf-GEFs are characterized by the catalytically active conserved
Sec7 domain, and can be divided into two large families: the low-
molecular-weight GEFs (,100 kDa) and the high-molecular
weight GEFs (.100 kDa) [6,7,8]. The low-molecular-weight
GEFs are not found in the yeast, suggesting a function specific
to higher eukaryotes. This family contains in human ARNO,
cytohesin-1, GRP1/ARNO3 and EFA6. Several studies suggest
that these small GEFs are mainly involved in signal-transduction
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endocytosis, mainly by activation of the class III Arf6. The high-
molecular-weight GEFs have orthologues in all eukaryotes
investigated, suggesting evolutionary-conserved functions in mem-
brane trafficking. The three human large Arf-GEFs, known as
GBF1, BIG1, and BIG2, are all sensitive to the fungal metabolite
brefeldin A (BFA). BFA inhibits the secretory pathway by inducing
the release of coat complexes from the membranes, a collapse of
the Golgi apparatus to the ER, a tubulation of the TGN and
merging of the TGN with endosomal compartments [9,10,11,12].
GBF1 acts at the ER/Golgi interface and within the Golgi
stacks. GBF1 directs the assembly of COPI onto membranes and
plays a key role in transport to and through the Golgi (for
examples see [13,14,15,16]). Less is known about the functions of
BIG1 and BIG2 which were initially characterized as part of the
same macromolecular complex (.600 kDa) [17]. BIG1 colocalizes
with clathrin and AP-1 [17] and to a lesser extent with TGN38,
but not with COPI [18]. In serum-starved cells, BIG1 can
translocate into the nucleus [19] suggesting a role in a stress-
induced signaling pathway. Silencing of BIG1 expression induces a
minor disruption of the Golgi complex, described as a looser
Golgi, and a profound defect in the maturation of b1-integrin
followed by a subsequent defect in the spreading of the cells [20].
BIG2 has been shown to colocalize with the adaptor complex
AP-1 [17] on the TGN, and with GGA3 and the cation-
independent mannose-6-phosphate receptor (CI-MPR) [21,22]. It
does not colocalize with early- or late-endosomal markers such as
EEA1 and LAMP1 [22], but seems to be involved in the
maintenance of the endosomal compartment integrity and in the
recycling of the transferrin [21,23]. Mutations in BIG2 are found
in genetic disorders leading to microcephaly and periventricular
heterotopia [24], highlighting important and specific functions of
BIG2 in humans. The lack of defects in tissues outside of the
central nervous system is indicative of redundancy with other large
Arf-GEFs. BIG1 and BIG2 have both been characterized as
protein kinase A-anchoring proteins (AKAP) [25]. Furthermore,
their phosphorylation by PKA decreases their GEF activity and
induces their translocation to membranes, suggesting a possible
role of BIGs in crosstalk between Arf and PKA pathways [25,26].
While there have been several studies of large Arf-GEF function
exploiting the power of RNAi, data from these studies are
conflicting and often assume complete redundancy between BIG1
and BIG2 in particular. In this study, we have performed siRNA-
mediated depletion of BIG1 and BIG2 in human cells to better
understand their individual functions.
Results
Depletion of BIG1 or BIG2
To determine the individual functions of the large Arf-GEFs, we
depleted these proteins from cells using RNA interference.
Immunoblotting with antibodies directed against each of these
proteins showed that we were able to deplete them with a pool of
two different duplexes after 72 hours of transfection (Fig. 1A). The
expression level of GBF1 remains unaffected and duplexes
targeting BIG1 do not reduce the levels of BIG2 and vice versa.
The quantification by densitometry from 3 to 4 independent
experiments showed that BIG2 was depleted to 86% and BIG1 to
75% across the overall cell population (Fig. 1B).
BIG2 is needed for the endosomal compartment integrity
In order to determine the effect of these depletions on the gross
morphology of different subcellular compartment, we performed
immunofluorescence on depleted cells with antibodies specific for
several different organelles. First, the depletion of BIG1 or BIG2
had no effect on ERES (as revealed by COPII labelling, Fig. S1,
COPII), or late endosomes/lysosomes (CD63 labelling, data not
shown). BIG2 has been proposed to act at the TGN-endosome
boundary [18,21,27]. Two different groups have suggested a role
of BIG2 in the recycling of transferrin, and its depletion induces an
Figure 1. Depletion of human large-GEFs using siRNA. A: HeLa cells were transfected without siRNA (Mock), with non-targeting siRNA
duplexes (Control), or with siRNA targeting indicated GEF (GBF1, BIG1, BIG2). Cell lysates were then immunoblotted for antibodies indicated on the
left (Blot). Arrowhead points to the specific band for BIG1. B: Western-blots were quantified by densitometry and protein contents are expressed as
percentage of mock-transfected cells. Results are presented as mean +/2 s.e.m., n=3–4, asterisk means p,0.05 as compared to cells transfected with
a non-targeted siRNA (Control). Molecular-mass markers are shown in kDa in all figures.
doi:10.1371/journal.pone.0009898.g001
BIG1 and BIG2 Specificity
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juxtanuclear region [21,23]. BIG2 depletion seemed not to have
an effect on the gross morphology or distribution of early
endosomes (EEA1 labelling, Fig. S1, EEA1). Transferrin bound
to its receptor is believed to move sequentially to early-endosomes,
then to recycling-endosomes (REs) and subsequently is recycled to
the cell surface. The half-life of these events has been measured to
be between 5 minutes (if transferrin is recycled independently of
the REs) or 15–30 minutes (through REs) [28,29]. In order to
investigate the effect of BIG2-depletion on endosomal compart-
ments, we imaged live-cells after a 30 minutes pulse of fluorescent
transferrin. As shown in Fig. 2A, BIG2-depletion induced an
extensive tubulation of the endosomal compartment. Quantifica-
tion shows that in BIG2-depleted cells, 70% of cells show
tubulated transferrin-positive endosomes. This is consistent with
previously published data [21,23]. Recycling endosomes are
believed to be a tubulo-vesicular organelle [30], but such an
extensive tubulation was never observed either in control cells or
in BIG1-depleted cells. Tubules observed in BIG2-depleted cells
appeared to be very stable over time (see Movie S1) and vesicles
were seen to move apparently alongside these tubules. These
vesicles are probably early-endosomes or transport intermediates,
known to associate with microtubules [31]. This suggests that these
tubules themselves elongate alongside the microtubules, as it has
been described for BFA-induced endosomal tubules [32,33]. We
found that only a subpopulation of these tubules is preserved upon
fixation, precluding any further analysis by standard immunoflu-
orescence techniques. Nevertheless, as shown in Fig. S2A, the
microtubule network seemed to be completely unaffected by
BIG2-depletion.
Previous work using overexpression of dominant negative
mutants of BIG2, which also tubulates the endosomal network,
Figure 2. Depletion of BIG2 induces the tubulation of the endosomal compartment. A: HeLa cells depleted using siRNA duplexes as
indicated were loaded with fluorescent transferrin (Tfn-A568) for 30 minutes prior to live-cell imaging. Movie S1 shows the stability of the BIG2-
depletion induced tubules. B: Tfn-A568 loaded cells were co-labelled using GFP-Rab11. Single optical z-sections are shown resulting in the presence
of some out-of-focus light, and panels below show enlarged regions. Bar=10 mm in all figures otherwise stated.
doi:10.1371/journal.pone.0009898.g002
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compartments [21,34]. Using live cell imaging, we find that BIG2
depletion induces transferrin-positive tubules that label with GFP-
Rab11 (Fig. 2B). Notably, BIG2 suppression induces a very
extensive tubulation of the GFP-Rab11-labelled compartment
(Fig. 2B). This is consistent with our time of loading of fluorescent
transferrin (30 minutes) which labels primarily recycling (i.e.
Rab11-positive) endosomes. The extensive cytosolic background of
GFP-Rab11 precludes full quantitative evaluation of tubulation
Importantly, tubulation of endosomal compartments was never
seen following suppression of BIG1.
Effect of BIG1 depletion on Golgi organization
As shown in Fig. 3A, and quantified in Fig. 3B, depletion of
BIG1 but not of BIG2 induced a fragmentation of the Golgi
apparatus. This fragmentation was never observed in BIG2-
depleted cells, looking at both cis-Golgi markers GM130 and
giantin (Fig. 3A and see also Fig. S1 for a direct comparison).
Despite having this profound effect on Golgi organization, BIG1-
depletion had no effect on either the Golgi population of COPI or
on the punctuate labelling in the cell periphery (Fig. S1, COPI).
The lack of effect on Golgi organization following BIG2-depletion
could be explained by a compensation of loss of BIG2 function by
BIG1. In order to investigate this, we examined cells depleted of
both BIG1 and BIG2. Single or double-depleted cells were stained
for the Golgi and the number of Golgi fragments per cell
quantified. Double-depletions of BIG1 plus BIG2, did not result in
a change of the Golgi fragmentation (Fig. 3A, 3B), indicating that
they might have different functions in the cell.
To validate these findings further we suppressed BIG1 using our
two siRNA duplexes separately (labelled as siRNA A and B).
Highly effective suppression of BIG1 expression across a
population of cells is seen when using the BIG1 ‘‘A’’ duplex with
less effective suppression when using the BIG1 ‘‘B’’ duplex
(Fig. 3C). On quantitation of the Golgi fragmentation phenotype,
we find that both duplexes cause a significant disruption of Golgi
structure (Fig. 3D), evident from giantin labelling (Fig. 3E).
The quantification of the number of Golgi-structures per cell
revealed a dramatic fragmentation of the Golgi in BIG1-depleted
cells (Fig. 3A, B). The same phenotype was obtained using only
single siRNA duplex to deplete BIG1 (Fig. 3C, D, E). In order to
ensure the specificity of the BIG1-siRNA phenotype on the Golgi
morphology, and to rule out the possible off-target effects of the
Figure 3. BIG1 suppression induces Golgi fragmentation. A: GM130 labelling reveals fragmentation of the Golgi apparatus following
suppression of BIG1 or BIG1 and BIG2 together, but control siRNA duplexes or duplexes targeting BIG2 alone do not induce this phenotype. B: After
applying the same threshold to all images, the number of Golgi fluorescent particles per cell was determined as described in ‘‘Materials and
Methods’’. Results are presented as mean +/2 s.e.m., asterisk means p,0.05 as compared to Control-depleted cells, n=3. C: BIG1 suppression using
individual siRNA duplexes was monitored by immunoblotting. Tubulin is used as a loading control. D: Quantification of Golgi-fragmentation done as
in B shows that both individual siRNA give a similar phenotype. E: Cells depleted of BIG1 using individual or pooled duplexes were labelled with
antibodies against the Golgi matrix protein giantin (in green) and nuclei are counterstained with DAPI (in blue).
doi:10.1371/journal.pone.0009898.g003
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a HA-tagged mutant BIG1 cDNA that is resistant to the BIG1
‘‘A’’ siRNA duplex (HA-BIG1mut). As shown in Fig. 4A, cells
expressing HA-BIG1mut after depletion of endogenous BIG1
showed a compact and juxtanuclear Golgi as in control cells
consistent with rescue of the siRNA phenotype. Quantification of
these data validated the rescue of phenotype (Fig. 4B). It has to be
noted that in these experiments the control cells seems to have a
looser Golgi (i.e. 40% of cells have more than 14 Golgi particles
per cell). An explanation to this could be that those cells have been
transfected by siRNA using calcium phosphate transfection and
then have been transfected by cDNA using Lipofectamine2000
(see ‘‘Materials and Methods’’). The cumulative toxicity of both
transfections could explain the discrepancy with the quantification
in Fig. 3B and 3E). Importantly, overexpression of His-tagged
BIG2 could not rescue the Golgi dispersion phenotype in any cells
examined (Fig. 4C).
In order to investigate whether Golgi fragmentation caused by
BIG1 suppression perturbs the secretory pathway, we first used the
model cargo protein tsO45-G-YFP. This glycoprotein can be
accumulated in the ER at 39.5uC and then released as a relatively
synchronous wave at 32uC [35,36]. In control cells, tsO45-G-YFP
reached the Golgi apparatus after 45 minutes of export, and the
plasma membrane within 2 hours (Fig. 5A, Control). In BIG1-
depleted cells affected for the Golgi, tsO45-G-YFP was still able to
reach the Golgi apparatus and subsequently the plasma membrane
(Fig. 5A, BIG1). Gross perturbation of ER-to-Golgi transport
results in a redistribution of b1,4-galactosyltransferase (GalT),
which is a trans-Golgi resident enzyme [37] to the ER [37,38].
Localization of endogenous GalT was unperturbed in BIG1-
depleted cells (Fig. 5B). While clearly functional, we also
determined whether these scattered Golgi elements retained the
same cis-trans polarity as the Golgi in unperturbed cells. We
labelled cells with antibodies directed against GM130, a cis/
median-Golgi marker, and TGN46, a well known marker of the
TGN. The Golgi mini-stacks obtained in BIG1-depleted cells
retained their cis-trans polarity, as is seen after nocodazole
treatment in control cells (Fig. 5C, control cells+Nz). It should be
noted that the overall expression level of several markers (GM130,
Golgin-97, and ERGIC-53) was not altered by any depletion as
assessed by western-blot (data not shown). This suggests that the
observed fragmentation of the Golgi is not due to a loss of these
key matrix proteins, and reinforces the specificity of this phenotype
caused by BIG1 depletion.
In order to investigate if this Golgi fragmentation is due to a
general fragmentation of the Golgi or a loss of interaction with the
microtubule network, we treated the cells with nocodazole prior to
quantification of the Golgi-particles number. As shown in Fig. 6A
and quantified in Fig. 6B, when BIG1-depleted cells are treated by
nocodazole, a higher level of fragmentation can be achieve
compared to untreated depleted cells. This suggests that the
fragmentation of the Golgi apparatus in BIG1-depleted cells is not
due to a loss of interaction with microtubules but more likely to a
break-up of cohesion between Golgi elements with these
fragmented ministacks remaining anchored onto the microtubules.
It should be noted that the actin cytoskeleton was also unperturbed
on BIG1 suppression (Fig. S2B).
This dispersed Golgi phenotype is highly reminiscent of that
seen on depletion of Golgi matrix proteins GRASP65 and GM130
[39]. In order to characterize the molecular mechanism causing
this Golgi fragmentation, we investigated the recruitment of
several Golgi matrix proteins known to be involved in structural
maintenance of the Golgi apparatus. Immunofluorescence label-
ling showed that the peripheral Golgi matrix protein GRASP65
[40,41] was still associated with the fragmented Golgi (Fig. S3A).
Moreover, the antibody used recognizes the C-terminal part of the
protein, which is cleaved during apoptotic process leading to the
fragmentation of the Golgi [42]. The fact that this antibody detects
GRASP65 on the fragmented Golgi together with the normal
DAPI staining of the nuclei showed that the fragmentation of the
Golgi apparatus in BIG1-depleted cells is therefore not a result of
an early apoptotic process. Furthermore, the Golgi matrix proteins
p115 (Fig. S3B), GM130 (see Fig. 3A, 5C and S1), giantin (Figs. 3E,
5B, S1 and others), and the TGN-localized protein golgin-97 (data
not shown) are still recruited to the fragmented Golgi. BIG1 has
been shown to be phosphorylated by PKA and proposed to be an
AKAP [25,26]. The regulatory subunit RIIa of PKA is mainly
localized in the juxtanuclear region [43], and recently has been
involved in the maintenance of the Golgi apparatus [44]. Fig. S3C
shows that the endogenous regulatory subunit RIIa is still present
on Golgi membranes following BIG1 depletion. This shows that
the maintenance of Golgi structure does not involve the AKAP
activity of BIG1, and that BIG1 is not the primary factor
maintaining a Golgi pool of PKA.
Clathrin adaptors associated with the TGN are recruited in an
Arf-dependent manner [45,46]. It has been shown that endoge-
nous and overexpressed BIG1 colocalize with the clathrin adaptor
AP-1 on the TGN. In our hands, the limited colocalization
between AP-1 and TGN46 prevented us from accurately defining
the recruitment of AP-1 onto the TGN (Fig. S4A). To address this
question, we used HeLa cells stably expressing a CD8-tagged
MPR [47] which gives a better colocalization with AP-1. As shown
in Fig. S4B, BIG1 depletion did not alter AP-1 localization to the
TGN. The peripheral punctate pool of AP-1 was also unchanged,
presumably representing peripheral endosomes as described
elsewhere [48]. The GGA proteins (GGA1, GGA2, and GGA3)
are monomeric clathrin-adaptors that are involved in export of
cargo mainly from the TGN to the endosomes [3,49]. As shown in
Fig. S5, the three GGAs were found to be still recruited on the
Golgi mini-stacks in BIG1-depleted cells. Similarly, depletion of
BIG2 did not affect recruitment of the GGAs to the TGN (data
not shown). These data are in accordance with the recent study
showing that neither the single depletion of BIG1 or BIG2 nor the
double depletions resulted in a loss of GGA proteins from the
TGN membranes [34].
Because these Arf effectors are still recruited to the fragmented
Golgi membranes induced by BIG1 depletion, it is tempting to
postulate that function of BIG1 in maintaining the structure of the
Golgi is independent of its GEF activity. Consistent with this, and
as shown in Fig. 7, Arf1-GFP is still recruited to the Golgi
fragments in BIG1-depleted cells.
Discussion
Previous studies of large Arf-GEF function have largely involved
the overexpression of mutant forms of these proteins or siRNA-
mediated suppression of expression. In most cases examining the
roles of BIG1 and BIG2 in particular, the two proteins are treated
as redundant and have been suppressed simultaneously in cells.
While this clearly eliminates any issues arising from redundancy,
such experiments will of course miss any specific roles for these
proteins. Furthermore, the expression of dominant negative or
constitutively active forms of the large Arf-GEFs could result in
formation of complexes that are not physiologically relevant. In
our study, we have undertaken a comparative analysis of the two
large Arf-GEFs BIG1 and BIG2, targeting each individually. A key
goal was to define any non-redundant functions as well as
reconcile considerable conflicting data in this field.
BIG1 and BIG2 Specificity
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Overexpression of a catalytically inactive mutant of BIG2
induces the formation of tubules which are positive for several
markers of the recycling endosomes (Rab4, Rab11 and transferrin-
receptor) and negative for the TGN marker TGN46 and early as
well late endosomes/lysosomes (Rab5, Rab7, EEA1 and LAMP1)
[21]. In our hands siRNA depletion of BIG2 recapitulates these
effects, inducing the tubulation of recycling endosomes positive for
Rab11-GFP. Together these data indicate that endosomal
tubulation is a specific phenotype resulting from BIG2 perturba-
tion and that endosome morphology cannot be compensated for
by BIG1. In contrast, while previous work has shown that
suppression of both BIG1 and BIG2 results in loss of AP1 from
TGN membranes, we find that suppression of BIG1 alone does
not affect AP1 recruitment consistent with a non-redundant
function of BIG1 and BIG2 at the TGN [34].In agreement with
other findings, suppression of BIG1 does not result in a loss of
GGA from membranes.
A specific role for BIG1 in the maintenance of Golgi
structure
The key finding from our work is that suppression of expression
of BIG1 results in a fragmentation of the Golgi apparatus. This
phenotype is similar to one previously described [20], but the
effect was only detectable by electron microscopy. Previous double
depletion of BIG1 and BIG2 resulted in the dispersion of the TGN
with no apparent changes in the Golgi morphology [50]. A
potential explanation for this would be an incomplete suppression
of BIG1 expression in these experiments. These data [50] and
others [34] do however suggest redundant functions of BIG1 and
BIG2 at the TGN. Our data show that maintenance of Golgi
structure is one function of BIG1 that cannot be compensated for
by BIG2. Despite retention of Arf1-GFP at the Golgi, it is possible
that other Arf proteins fail to be recruited to the Golgi mini-stacks
in BIG1-depleted cells. Another interpretation of this is that the
role of BIG1 in maintaining the integrity of the Golgi apparatus is
independent of its function as an Arf-GEF.
The Golgi fragmentation phenotype that we observe is distinct
from that seen with nocodazole treatment in that the fragments
are larger and do not become scattered throughout the cytoplasm,
in addition we observe no changes in the integrity of the
microtubule cytoskeleton following BIG1 suppression. Moreover,
nocodazole-treatment of BIG1-depleted cells highly suggests that
the Golgi mini-stacks are still organized by microtubules. The lack
of correlation between the level of BIG1 knockdown and the
extent of Golgi fragmentation could be indicative of a threshold
having been reached beyond which one sees no further phenotype.
This would be consistent with the results following addition of
nocodazole. This phenotype is highly reminiscent of that seen
following suppression of expression of Golgi matrix proteins [39].
Despite this, we did not detect any perturbation in the localization
to the Golgi of, or stability of GM130, GRASP65, giantin, or
p115. BIG1 interacts with myosin IXb [51]. Little is known of the
function of myosin IXb but it has been localized throughout the
cytoplasm and on the Golgi apparatus. It contains a RhoGAP
domain and it is tempting to postulate that myosin IXb is needed
for the maintenance of the Golgi apparatus through integration of
Golgi membranes with the actin cytoskeleton.
A further point from our experiments is that we find that BIG1
is not absolutely required for the recruitment of GGAs to
membranes. This is likely again due to redundancy with other
Arf-GEFs, possibly BIG2 [50] but also somewhat surprisingly,
GBF1 [52]. This reinforces the difficulty in assigning specific
function to these Arf-GEFs and underlies the specificity of the
Golgi fragmentation phenotype on suppression of BIG1.
Materials and Methods
Materials
Nocodazole was from Sigma, Alexa568-conjugated phalloidin
and transferrin from Invitrogen. Antibodies used were as followed:
mouse monoclonal anti-GBF1 (BD Transduction Laboratories);
rabbit polyclonal anti-BIG1 and anti-BIG2 (Bethyl Laboratories);
monoclonal mouse anti-a-tubulin DM1A (Labvision); polyclonal
rabbit anti-COPII (Sec24C) was as described [53]; monoclonal
mouse anti-EEA1 (BD Transduction Laboratories); monoclonal
anti-AP-1 (Sigma); monoclonal anti-GGA3 (BD Transduction
Laboratories); polyclonal anti-COPI (BSTR) [38]; rabbit poly-
clonal anti-GGA1 and anti-GGA2 were kindly provided by
Jennifer Hirst (CIMR, Cambridge, UK); rabbit polyclonal anti-
giantin (Covance); monoclonal mouse anti-GM130 (BD Trans-
duction Laboratories); polyclonal sheep anti-TGN46 (AbD
Serotec); monoclonal mouse anti-RIIa PKA (BD Transduction
Laboratories); monoclonal mouse anti-b1,4-galactosyltransferase
(CellMab AB); polyclonal sheep anti-GRASP65 and monoclonal
mouse anti-p115 were kindly provided by Jon Lane (University of
Bristol, Bristol, UK); polyclonal rat and monoclonal mouse anti-
CD8 were kindly provided by Pete Cullen (University of Bristol,
Bristol, UK) as well as plasmid encoding for GFP-Rab11. Cy-dye
and HRP-conjugated secondary antibodies were from Jackson
Immunoresearch. Monoclonal mouse anti-CD63 (Biogenesis) was
kindly provided by Harry Mellor (University of Bristol, Bristol,
UK). Plasmid encoding Arf1-GFP was kindly provided by Jennifer
Lippincott-Schwartz [54]. HeLa cells stably expressing CD8-MPR
were a kind gift from Matthew Seaman (CIMR, Cambridge, UK)
[47].
Molecular cloning and site-directed mutagenesis
To obtain a siRNA-resistant form of BIG1, a HA-tagged
version kindly provided by M. Vaughan [55] was used as a
template for site-directed mutagenesis using the following sense
primer: 59- GGAACAAAAGATCAGGC(T/A)CC(T/A)GA(T/
C)GAATT(T/C)GTGGGTTTAGGGC -39 in combination with
its antisense primer. The nucleotides in brackets indicate the bases
that were changed to produce base substitutions T3261A,
T3264A, T3267C and T3273C, according to the human ORF
Figure 4. Rescue of Golgi fragmentation in BIG1-suppressed cells. A: Control cells, or those depleted of BIG1 expression were transfected to
express a HA-tagged mutant BIG1 (HA-BIG1mut) that is resistant to the siRNA. Cells were processed for immunofluorescence using anti-HA (green)
and anti-giantin (red) antibodies. Asterisks indicate transfected cells, showing the rescued phenotype in BIG1-depleted cells. B: Quantification of the
rescue phenotype. Cells were transfected with indicated siRNA and subsequently transfected to express HA-BIG1mut. The number of Golgi particles
per cell was counted as in Fig. 3B. Data are pooled from two independent experiments. The numbers on top of the bars indicate the number of cells
counted for each condition. C: BIG2 expression cannot rescue the fragmentation of the Golgi induced by BIG1-depletion. Control cells or those
depleted of BIG1 expression were transfected to express a His-tagged BIG2 (His-BIG2). Cells were labelled using anti-BIG2 (green) and anti-giantin
(red) antibodies. Asterisks indicate transfected cells, showing that overexpression of BIG2 does not rescued the phenotype in BIG1-depleted cells.
Three different examples are shown for BIG1-depleted cells.
doi:10.1371/journal.pone.0009898.g004
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G-YFP at 39.5uC. Cells were then shifted to 32uC to allow the trafficking of the viral protein for 0, 45, or 120 minutes as indicated. Trafficking of the
viral protein is indistinguishable between control and BIG1 depleted cells. Note the fragmentation of the Golgi in BIG1 depleted cells confirming the
efficacy of BIG1 suppression. B: The fragmented Golgi in BIG1-depleted cells is still populated with endogenous galactosyltransferase (GalT). Depleted
HeLa cells were processed for immunofluorescence with anti-GalT (green in merge) and anti-giantin (red) antibodies. C: Scattered Golgi elements
induced by BIG1-depletion retain their cis-trans polarity. HeLa cells transfected with siRNA duplexes as indicated were incubated with nocodazole
(Nz) to depolymerize the microtubules, methanol-fixed, and processed for immunofluorescence with anti-TGN46 (green in merge) and anti-GM130
(red) antibodies.
doi:10.1371/journal.pone.0009898.g005
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restriction site (underline sequence) to allow simple screening of
colonies for mutant plasmids. The resulting construct was fully
sequenced to ensure the fidelity of the PCR. Only a single
mutation was found (C1670T), resulting in a A557F change in the
amino acid sequence.
Tissue culture, transfection and immunoblotting
HeLa cells (ATCC CCL-2) were grown as described before
[56]. For each large GEF, two siRNA duplexes were designed and
ordered (MWG Biotech) as follows (sense oligonucleotide sequenc-
es): BIG1 (‘‘A’’ AGAUCAGGCUCCUGAUGAATT; ‘‘B’’ ACA-
GAGUCCUCCUCAUGGATT); BIG2 (‘‘A’’ UACUGAACA-
UAGCUGUAUATT; ‘‘B’’ AGGCCUUCAACUCCAAUUAT-
T). As a targeted control, two different unrelated siRNA were used
in this study: lamin A/C [56] or GL2c directed against firefly
luciferase [57] (CGUACGCGGAAUACUUCGATT). Both con-
trol oligonucleotides gave undistinguishable absence of effect on all
the organelles looked at and are referred in this study as the
‘‘Control’’. Cells were transfected as described [56] using calcium
phosphate for siRNA or FuGENE6 (Roche Applied Science) or
Lipofectamine
TM 2000 (Invitrogen) for DNA. To confirm the
depletion by immunoblotting, cells were washed twice in ice-cold
PBS, scrapped in ice-cold buffer A [50 mM Tris-HCl, 150 mM
NaCl, 1% Triton X-100, Protease Inhibitor Cocktail Set V
(Calbiochem), pH 7.4], left on ice for 30 minutes, insoluble
material was pelleted by centrifugation (10,000 g for 10 minutes at
4uC). The protein concentration was assayed using BCA
TM
Protein Assay Kit (Pierce/Thermo Fisher) according to the
manufacturer’s instructions. Same amount of proteins was diluted
in SDS-PAGE sample buffer, denatured at 70uC for 10 minutes,
and proteins were separated by electrophoresis on Tris-Acetate
or Bis-Tris gels (Invitrogen), transferred to nitrocellulose
and immunoblotted. Blots were developed using ECL (GE
Healthcare).
Immunofluorescence and live cell imaging
Living and fixed cells were imaged by using widefield
microscopy as previously described [56]. If not stated differently,
all images shown are extended focus through sample. Where
indicated, cells were treated with nocodazole (5 mM) or with an
equal volume of DMSO (vehicle only) for 1 h in culture medium.
For immunofluorescence, cells were fixed with methanol for 4
minutes at 220uC, blocked with using PBS containing 3% bovine
serum albumin and incubated with primary antibodies for 1 hour.
For staining of EEA1, cells were fixed with 3.5% paraformalde-
hyde for 15 minutes and permeabilized with 0.1% Triton X-100 in
PBS for 5 minutes. For Alexa568-transferrin uptake, HeLa cells
were grown on glass-bottom dishes (MatTek Corp.) and Alexa568-
transferrin was diluted in imaging medium (DMEM without
phenol red supplemented by 20 mM HEPES pH 7.4) at a final
concentration of 100 mg.ml
21. Images and time-lapse sequences
were acquired at 37uC, 30 minutes after Alexa568-transferrin
incubation.
tsO45-G-YFP transport assay
Quantitative transport assay of tsO45-G-YFP was essentially
done as described before [56]. Briefly, depleted cells were infected
with Adenovirus engineered to express tsO45-G-YFP for 1 hour at
37uC, and then washed and transferred to 39.5uC for 16 hours.
Transport assays were carried out by shifting cells to 32uC for the
times indicated. The cells were then paraformaldehyde-fixed and
proceeded for immunofluorescence as described above.
Image and statistical analysis
All images were processed using Photoshop CS (Adobe), and
ImageJ. Movies were compiled in QuickTime Pro using ‘‘Photo
JPEG’’ compression. For quantitative analysis of the Golgi/TGN
fragmentation, the same threshold was applied to all images, and
the number of Golgi-derived particles per cell was determined
using the ‘Analyze Particles’ function of the ImageJ software, as
described elsewhere [44]. Between 50 and 200 cells were counted
for each condition, and all results from 3–7 independent
experiments were pooled and are presented as means +/2
s.e.m. Statistical analysis was performed by Student’s two-tailed t-
test for unpaired data and a probability level of 0.05 was
considered significant.
Figure 6. The Golgi mini-stacks in BIG1-depleted cells are still
coordinated on microtubules. A: HeLa transfected for indicated
siRNA were treated or not with nocodazole (Nz) and stained for giantin
and a-tubulin. B: Quantification of Golgi-particles was done as in
previous figures. A higher fragmentation of the Golgi can be achieved
by treating BIG1-depleted cells with nocodazole, suggesting that the
Golgi mini-stacks are still coordinated on microtubules. Asterisks mean
p,0.05 as compared to control untreated cells, # means p,0.05 as
compared to nocodazole-treated BIG1-deplepted cells.
doi:10.1371/journal.pone.0009898.g006
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Figure S1 Subcellular compartments morphology in BIG1 or
BIG2-depleted cells. HeLa cells were depleted with indicated
siRNA duplexes, fixed and proceeded for immunofluorescence
with antibodies against COPII, EEA1, COPI, Giantin or GM130.
Bar=10 mm in all figures.
Found at: doi:10.1371/journal.pone.0009898.s001 (2.12 MB TIF)
Figure S2 The cytoskeleton is not altered in BIG-depleted cells.
HeLa cells depleted by indicated siRNA duplexes were stained
using antibodies against Giantin and against a-tubulin (panel A) or
labelled with Alexa568-phalloidin (panel B).
Found at: doi:10.1371/journal.pone.0009898.s002 (2.02 MB TIF)
Figure S3 Recruitment of Golgi proteins to the Golgi-mini-
stacks is not impaired in BIG1-depleted cells. Control or BIG1-
depleted cells were subjected to immunofluorescence for indicated
antibodies. GRASP65, PKA-RIIa and p115 are still localized to
the mini-stacks co-labelled with giantin.
Found at: doi:10.1371/journal.pone.0009898.s003 (3.61 MB TIF)
Figure S4 BIG1 function on the Golgi maintenance in
independent of the recruitment of AP-1. A: Depleted cells treated
or not with nocodazole (Nz) were immunolabelled with an anti-
TGN46 antibody (green in merge) and with an anti-AP-1 antibody
(red in merge). B: HeLa cells stably expressing a CD8-tagged MPR
were stained with an anti-CD8 antibody (green in merge) and an
anti-AP-1 antibody (red in merge).
Found at: doi:10.1371/journal.pone.0009898.s004 (5.77 MB TIF)
Figure S5 Recruitment of GGAs is not affected by BIG1-
depletion. HeLa cells expressing CD8-MPR were treated as in Fig.
S3 and labelled with an anti-CD8 antibody (green) and with anti-
GGA1, GGA2 or GGA3 antibodies as indicated (red in merge).
Found at: doi:10.1371/journal.pone.0009898.s005 (4.44 MB TIF)
Movie S1 Depletion of BIG2 induces the formation of stable
endosomal tubules. HeLa cells depleted for BIG2 were loaded
with Alexa568-conjugated transferrin for 30 minutes and images
using wide-field time microscopy. Note some vesicles moving
alongside the tubules (most evident on the top-left corner).
Found at: doi:10.1371/journal.pone.0009898.s006 (4.14 MB
MOV)
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